New reproductive assay from Siemens Healthineers provides critical information to guide in vitro fertilization decisions

March 14, 2024
The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information.

Siemens Healthineers now offers the Anti-Müllerian Hormone (AMH) Assay to quickly evaluate ovarian reserve.

The AMH Assay aids a physician's initial assessment about initiating in vitro fertilization (IVF) with a patient. Physicians use AMH test results, which indicate the volume of remaining eggs, to determine whether a patient's ovaries may respond favorably to IVF.

The insight the AMH Assay from Siemens Healthineers provides can help doctors better understand a patient's ovarian reserve and assist in consulting patients about whether to undergo IVF with a view to likelihood of success. Once in treatment, data gained from AMH testing can help reduce the number of IVF attempts, which can reduce financial cost as well as minimize adverse reactions associated with treatment.

Visit Siemens Healthineers for more news